Share on StockTwits

Sanofi SA (NYSE:SNY) has been given a consensus recommendation of “Hold” by the twelve brokerages that are presently covering the company, reports. Seven investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $55.00.

Sanofi SA (NYSE:SNY) traded down 0.70% during mid-day trading on Monday, hitting $54.14. 233,486 shares of the company’s stock traded hands. Sanofi SA has a 1-year low of $46.95 and a 1-year high of $54.64. The stock has a 50-day moving average of $53.38 and a 200-day moving average of $51.70. The company has a market cap of $143.0 billion and a P/E ratio of 28.09.

Sanofi SA (NYSE:SNY) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.81 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.84 by $0.03. On average, analysts predict that Sanofi SA will post $3.53 earnings per share for the current fiscal year.

SNY has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Sanofi SA in a research note on Friday. They now have a $57.00 price target on the stock. Finally, analysts at S&P Equity Research reiterated a “hold” rating on shares of Sanofi SA in a research note on Wednesday, April 30th.

Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.